Sponsor:
M.D. Anderson Cancer Center
Code:
NCT07407920
Conditions
Anatomic Stage I Breast Cancer AJCC v8
Anatomic Stage II Breast Cancer AJCC v8
Early Stage HER2-Positive Breast Carcinoma
Early Stage Triple-Negative Breast Carcinoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Biospecimen Collection
Hormone Therapy
Pembrolizumab
Pertuzumab
Trastuzumab
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2026-07-02. This information was provided to ClinicalTrials.gov by M.D. Anderson Cancer Center on 2026-06-24.